Exploring the universe of oral anticoagulation in patients with non-valvular atrial fibrillation: continuing the journey

Event: ESC CONGRESS 2015
Topic: Atrial fibrillation (AF)
Session type: Satellite Symposium
Sponsored by BMS-Pfizer Alliance
Date: 30 August 2015
Time: 18:30 - 20:00

6 presentations in this session

What have we learned and how can we advance antithrombotic treatment further?

Speaker: Professor G. Lip (Liverpool, GB)
Thumbnail

Improving patient outcomes: how has the treatment landscape evolved?

Speaker: Professor P. Kirchhof (Hamburg, DE)
Thumbnail

Overcoming the dilemma of stroke vs bleeding risk.

Speaker: Professor S. Hohnloser (Frankfurt, DE)
Thumbnail

Exploring real-world evidence for oral anticoagulation.

Speaker: Professor G. Lip (Liverpool, GB)
Thumbnail

Optimising oral anticoagulation in routine clinical practice.

Speaker: Professor G. Montalescot (Paris, FR)
Thumbnail

The journey continues: future perspectives on improving patient care.

Speaker: Professor G. Lip (Liverpool, GB)
Thumbnail

6 speakers from this session

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
70 presentations
5 followers

Professor Paulus Kirchhof

University Heart & Vascular Center UKE Hamburg, Hamburg (Germany)
43 presentations
2 followers

Professor Stefan H Hohnloser

Johann Wolfgang Goethe University, Frankfurt (Germany)
27 presentations
1 follower

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
70 presentations
5 followers

Professor Gilles Montalescot

Sorbonne University, Paris (France)
24 presentations
1 follower

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
70 presentations
5 followers

This platform is supported by

logo Novo Nordisk